Accordingly, AMPK activation based on the low expression of SLC7A11 altering the cellular sensitivity to ferroptosis under HFD treatment was mechanistically responsible for the distinctive antitumor activity of SGF in obesity-related CRC. Here, SLC7A11 is linked to obesity due to melanocortin 4 receptor deficiency.